MedTrace Logo

Therapy of the Overactive Bladder Syndrome

NCT01314781 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2016-05-20

No results posted yet for this study

Summary

The aim of the present study is to investigate in patients with overactive bladder syndrome (OABS) whether a combination treatment of solifenacin with pelvic floor muscle training and whole body vibration training achieves a better treatment outcome than a treatment with solifenacin alone.

Conditions

Interventions

DRUG

solifenacin

solifenacin 5mg tablet once daily

PROCEDURE

PFMT and WBVT

pelvic floor muscle and whole body vibration training once a week

Sponsors & Collaborators

  • Astellas Pharma Inc

    collaborator INDUSTRY

  • Cantonal Hospital, Frauenfeld

    lead OTHER

Principal Investigators

  • Volker VV Viereck, physican · Cantonal Hospital, Frauenfeld

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2014-01-31
Completion
2015-03-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01314781 on ClinicalTrials.gov